Monthly Archives: October 2020

The largest cause of mortality in patients with inflammatory bowel disease (IBD) remains thrombo-embolic disease (TED). Recent reports have demonstrated that both monogenic and polygenic factors contribute to TED and 10% of ‘healthy’ subjects are genet… Continue reading →

Machine reading of endoscopic videos in an ulcerative colitis clinical trial shows promise in replacing central readers with excellent machine-to-human interobserver agreement for UCEIS and endoscopic Mayo score Continue reading →

“My spouse/child/roommate/friend/etc. was in contact with someone who was positive. What do I do?” — and other questions. Continue reading →

Vanderbilt University Medical Center, in collaboration with the University of Colorado and Beth Israel Deaconess Medical Center in Boston, is leading one of the first “telemedicine” clinical trials to test a potential treatment for COVID-19. Continue reading →

Exposure is defined as interactions greater than 10 minutes and closer than 6 feet. Look for any new onset of respiratory or flu-like symptoms, including cough, shortness of breath, loss of smell or taste (without other neurologic symptoms), diarrhea, … Continue reading →

With increasing COVID-19 cases and a rising positivity rate in Middle Tennessee, Nashville’s four largest hospitals joined together this week to appeal to the citizens of the region to practice diligent hand hygiene, remain socially distanced and wear … Continue reading →

Vanderbilt University Medical Center’s Infection Prevention Team is being recognized for their outstanding contributions during this year’s battle against the COVID-19 pandemic. Continue reading →

A snapshot of some of the numbers that help tell the story of COVID-19 at Vanderbilt. Continue reading →